Skip to content

To study the effectiveness of homoeopathic medicine strontium carbonicum in managing hypertension

A clinical study on the effectiveness of homoeopathic medicine strontium carbonicum in managing essential hypertension - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095139
Enrollment
30
Registered
2025-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Homoeopathic medicine Strontium carbonicum: Cases will be taken in detail and recorded in the structured case sheet formulated for the study.Basic Laboratory investigations with Lipid P

Sponsors

Department of homoeopathic materia medica white memorial homoeo medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients from different socio economic groups patients who give their valid consent to participate in this study stage 1 hypertensives . patients with either systolic bloodpressure 140-159 mm hg or diastolic blood pressure 90-99 mm hg or both

Exclusion criteria

Exclusion criteria: Patients suffering from Secondary Hypertension associated with any other Chronic debilitating systemic disorders like Pulmonary Tuberculosis, Cancer, Chronic Kidney disorders and autoimmune diseases. Suspicion of a secondary cause for hypertension arose from the physical examination or routine investigations .There was any kind of continued antihypertensive therapy for atleast six months .Patients were with labile hypertension (sometimes, but not always, arterial pressure in the hypertensive range, i.e. not sustained) .The cases were of malignant hypertension (SBP MORE THAN 180mm Hg and DBP MORE THAN 120 mm Hg) .Patients were suffering from isolated systolic hypertension grade 1 and 2 (SBP more than or equal to 140mmHg and or DBP less than 90 mm Hg), as was mostly found in elderly patients .Presence of any systemic disease in the patients who are already diagnosed or detected clinically.Patient s Age less than 35 years and Above 50 years.Persons under the influence of alcohol or smoking or tobacco or drugsabuse for atleast six months.Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
the primary outcome is to measure how much blood pressure is reducing after taking the medicine. it should be Lowering of either systolic or diastolic or both systolic and diastolic blood pressure by a minimum of systolic 14 mmHg And or diastolic 9 mmHg.These will be recorded once every 15 days for a minimum duration of three months, followed by monthly readings for an additional three monthsTimepoint: 3 months

Secondary

MeasureTime frame
Blood pressure coming in to the normal range of less than 130/80 mm hgTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Suseela Rufus

White Memorial Homoeo Medical College and Hospital

drsuseelarufus@gmail.com8428499199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026